drugset / Trial / NCT05298332
Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is a single center, open-label, 3-Cohort, parallel, single-dose, study to evaluate the PK, safety, and tolerability of ATI-2173 50 mg administered orally in Japanese, Chinese, and Non-Asian healthy subjects incorporating a food effect analysis in Non-Asian healthy subjects.
Timeline
- Start
- 2022-03-29
- Primary completion
- 2022-08-22
- Completion
- 2022-08-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FOSCLEVUDINE ALAFENAMIDE | Other / unclassified | 50 mg | Oral |